Navigation Links
A drug combination extends survival in refractory lung cancer patients
Date:6/2/2011

NEW YORK CITY Scientists have identified a drug combination, when used in advanced lung cancer patients, shows a survival advantage in patients who no longer respond to existing therapies. They found that bexarotene and erlotinib can each repress the critical cell cycle regulator: cyclin D1. The drug combination also broadened the reach to include a specific subset of patients, such as those resistant due to the presence of a ras mutation in their cancer. The study was published in the June issue of Cancer Prevention Research.

"Erlotinib has been found to be most effective in women of Asian descent who are never smokers with bronchioalveolar carcinoma, and who tend to have activating mutations of the epidermal growth factor receptor," said Ethan Dmitrovsky, M.D., an Associate Scientific Director of the Samuel Waxman Cancer Research Foundation and a senior author on the study. "None of the patients in our study fit that demographic profile."

In fact, the patients in the cohort who exhibited the greatest response included non-Asian men who were smokers. Advanced lung cancer patients with refractory disease have a survival of four months or less with traditional chemotherapy. The results of the study showed a median survival of five and a half months and longer. Three patients from the trial are now living two to four years beyond the expected average.

The study's results were recently duplicated by a group of MD Anderson scientists, noted Konstantin Dragnev, M.D., who led this trial and is an associate professor at Dartmouth Medical School, in Hanover, N.H.

The most exciting part of the research, which was funded in part by the Samuel Waxman Cancer Research Foundation, "is that scientists were able to make a dent in the ras mutation subset of patients," said Dmitrovsky, who is a professor at Dartmouth Medical School. "This area is an unmet medical need. These are often times the most difficult lung cancers to treat."'/>"/>

Contact: Jenny Song
jsong@waxmancancer.org
646-398-5277
Samuel Waxman Cancer Research Foundation
Source:Eurekalert

Page: 1 2

Related biology news :

1. Old stain in a new combination
2. Diabetes drug kills cancer stem cells in combination treatment in mice
3. Investigators identify cleat/natural grass combination may be less likely to result in ACL injury
4. Study: Grass, fungus combination affects ecology
5. Grape news: New treatment combination safe alternative to sulfur dioxide
6. Novocure reports data showing TTF therapy in combination with chemotherapy has the potential to increase overall survival for patients with advanced non-small cell lung cancer
7. Pertuzumab and trastuzumab combination improved efficacy for women with HER2-positive breast cancer
8. Combination therapy reduced HER2-positive breast cancers
9. Killing drug-resistant melanoma requires combination therapy
10. Combination therapy provides hope for cure of dangerous infections of cystic fibrosis patients
11. Microbubble-delivered combination therapy eradicates prostate cancer in vivo
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... a joint venture between The University of Texas at ... Science Center at San Antonio, has selected the winners ... Boice from UTSA and Lei Huang from the Health ... "Novel engineered ferritins for tracking and protecting neural stem ... is focused on finding a treatment for stroke through ...
(Date:7/30/2014)... study of dominance in female baboons suggests that the route ... mom, and to have lots of supportive sisters. , A ... strength, but by the rank of her mother - the ... be. For this reason, dominance rank in female baboons is ... mothers are guaranteed a good spot in the pecking order, ...
(Date:7/30/2014)... A team of biologists, led by Clemson University associate ... marine pest that will pave the way for novel ... bio-adhesives for medical and industrial applications. , The team,s ... examined the last larval stage of barnacles that attaches ... natural, possibly polymeric material that acts as an underwater ...
Breaking Biology News(10 mins):Supportive moms and sisters boost female baboon's rank 2Supportive moms and sisters boost female baboon's rank 3Study: Marine pest provides advances in maritime anti-fouling and biomedicine 2
... almost unbearably complex. Humans and mice, frogs and flies ... sequences during their relentless march from embryo to death. ... proteins behind the genomic wizard,s screen have a powerful ... the Stanford University School of Medicine. Until now, ...
... Researchers from the University of Leeds, UK, the Charit ... for Molecular Medicine (MDC) in Berlin, Germany, have discovered ... studies have identified how ,junk, DNA promotes the growth ... Constanze Bonifer (University of Leeds) and Dr Stephan Mathas ...
... , VANCOUVER, BRITISH COLUMBIA Although there is no ... in several genes are associated with the developmental brain ... may be involved with autism. Investigators will present ... Academic Societies (PAS) annual meeting in Vancouver, British Columbia, ...
Cached Biology News:New Stanford tool enables wider analyses of genome 'deep sequencing' 2New Stanford tool enables wider analyses of genome 'deep sequencing' 3'Junk DNA' drives cancer growth 2Study adds to evidence that autism has genetic basis 2
(Date:7/30/2014)... Toronto, Canada (PRWEB) July 30, 2014 ... been available in health services research for a ... an upswing in interest regarding the use of ... actual practice conditions. , By combining today’s powerful ... in the digital era, ‘big data’ holds significant ...
(Date:7/30/2014)... July 30, 2014 With the ... of personal health expenditure as well as the ... system, China diagnostic reagent industry has been developing ... 90%. In 2013, Chinese in vitro diagnostics market ... came from in vitro diagnostic reagents. , ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 Yuma ... facility and complementary therapies brings comprehensive cancer care ... state-of-the-art Yuma Regional Cancer Center has officially opened. ... the program includes services such as open, semi-private ... therapy, American Cancer Society Resource Center, hematology, rehabilitation ...
(Date:7/30/2014)... DIEGO , July 30, 2014   Epic ... designs and develops novel diagnostics to personalize and advance ... appoint of Gregory T. Lucier as chairman ... chairman and CEO of Life Technologies (formerly Invitrogen). Mr. ... as Epic commercializes its circulating rare cell analysis platform ...
Breaking Biology Technology:Leveraging ‘Big Data’ - Methodological Considerations in Health Services Research, New Webinar Hosted by Xtalks 2China Diagnostic Reagent Industry Report, 2013-2016 | Researchmoz 2China Diagnostic Reagent Industry Report, 2013-2016 | Researchmoz 3Sate-of-the-Art Yuma Regional Cancer Center Officially Opens 2Epic Sciences Appoints Greg Lucier as Chairman of the Board of Directors 2Epic Sciences Appoints Greg Lucier as Chairman of the Board of Directors 3
... Preparing for The Joint,Commission survey process within the ... internal services used to support patient,care, including all ... a result, a,healthcare institution must be prepared for ... direction and to involve any staff member. EH&E ...
... England, June 10 The Board of,Directors of ... global specialty,biopharmaceutical company, announces today that Graham Hetherington ... Executive Board Director on,1st July 2008., Graham ... senior financial,roles having most recently held positions as ...
... Calif., June 10 ,CryoLife, Inc. (NYSE: CRY ), ... that they have received a CE Mark for the ... endoscopic,browplasty or brow lift, a reconstructive plastic surgery procedure. ... in the European Community,(EU)., BioGlue will be distributed ...
Cached Biology Technology:White Paper Helps Hospitals Prepare Staff for Joint Commission Environment of Care Interview Sessions 2Graham Hetherington Appointed Chief Financial Officer and Board Director at Shire 2Graham Hetherington Appointed Chief Financial Officer and Board Director at Shire 3CryoLife's BioGlue(R) Surgical Adhesive Receives European Approval for use in Browlift Cosmetic and Reconstructive Plastic Surgery 2CryoLife's BioGlue(R) Surgical Adhesive Receives European Approval for use in Browlift Cosmetic and Reconstructive Plastic Surgery 3CryoLife's BioGlue(R) Surgical Adhesive Receives European Approval for use in Browlift Cosmetic and Reconstructive Plastic Surgery 4
Anti-BAR Immunogen: Peptide of aa 3-21 from human Bar Available Date: 38226...
... the HECT protein, E6-AP and ... suggests that this E2 is ... of non-""N-end rule"" protein substrates ... proteins as well as the ...
Anti-Mouse D011.10 TCR, Biotin (Clone KJ1-26) (mouse IgG2a)...
Reacts with methylated DNA from plants and vertebrates...
Biology Products: